|
欢迎您加入月均活跃用户100万＋的科研社区！
如您有任何建议，请；有合作推广需求，请点此洽谈。 
|
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI？是时候来Springer出书了！ |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | BREAST BREAST （此期刊被最新的JCR期刊SCIE收录） LetPub评分 6.6
52人评分
我要评分
声誉 7.6 影响力 5.4 速度 9.3 | |||||||||||||||||||||||||||||||
| 期刊ISSN | 0960-9776 | 
蝌蝌APP，让您与同行交流更轻松
 立即下载 | ||||||||||||||||||||||||||||||
| E-ISSN | 1532-3080 | |||||||||||||||||||||||||||||||
| 2024-2025最新影响因子 （数据来源于搜索引擎） | 7.9 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
| 实时影响因子 | 截止2025年5月19日：7.81 | |||||||||||||||||||||||||||||||
| 2024-2025自引率 | 2.50%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
| 五年影响因子 | 5.5 | |||||||||||||||||||||||||||||||
| JCI期刊引文指标 | 1.82 | |||||||||||||||||||||||||||||||
| h-index | 70 | |||||||||||||||||||||||||||||||
| CiteScore （ 2025年最新版） |
| |||||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||||
| 期刊官方网站 | https://www.sciencedirect.com/journal/the-breast | |||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/thebreast | |||||||||||||||||||||||||||||||
| 作者指南网址 | https://www.sciencedirect.com/journal/the-breast/publish/guide-for-authors | |||||||||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Tall Cell Carcinoma with Reversed Polarity of the breast: Clinicopathological insights, molecular profile, and future therapeutic directions Author: Lu, Ye; Kong, Xiangyi; Zhang, Wenxiang; Wang, Xiangyu; Pei, Shengbin; Fang, Yi; Gao, Jidong; Wang, Jing Journal: BREAST. 2025; Vol. 82, Issue , pp. -. DOI: 10.1016/j.breast.2025.104501 Explainable machine learning model for predicting internal mammary node metastasis in breast cancer: Multi-method development and cross-cohort validation Author: Xiang, Yirong; Tie, Jian; Zhang, Siyuan; Shi, Chen; Guo, Changkuo; Peng, Yushuo; Fan, Zhaoqing; Wang, Weihu Journal: BREAST. 2025; Vol. 82, Issue , pp. -. DOI: 10.1016/j.breast.2025.104517 Development and validation of a 10-gene signature for predicting recurrence risk in HR+/HER2-early breast cancer undergoing chemo-endocrine therapy Author: Wu, Xiaoyan; Lu, Xunxi; Zhang, Wenchuan; Zhong, Xiaorong; Bu, Hong; Zhang, Zhang Journal: BREAST. 2025; Vol. 82, Issue , pp. -. DOI: 10.1016/j.breast.2025.104484 Options for postoperative radiation therapy in patients with de novo metastatic breast cancer Author: Li, Chaofan; Wang, Yusheng; Fang, Biyun; Liu, Mengjie; Sun, Shiyu; Qu, Jingkun; Zhang, Shuqun; Du, Chong Journal: BREAST. 2025; Vol. 82, Issue , pp. -. DOI: 10.1016/j.breast.2025.104483 | |||||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足BREAST的语言要求，还能让BREAST编辑和审稿人得到更好的审稿体验，让稿件最大限度地被BREAST编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ USD3520; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：breast cancer、translational and clinical research、prevention、diagnosis、treatment、breast cancer surgery 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review APC费用补充说明：Original Research Articles: USD 3520; Reviews: USD 3520; Short Communications: USD 1560; Debates: USD 1560; Viewpoints: USD 1560; Case Reports: USD 1560; | |||||||||||||||||||||||||||||||
| 通讯方式 | CHURCHILL LIVINGSTONE, JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH, SCOTLAND, MIDLOTHIAN, EH1 3AF | |||||||||||||||||||||||||||||||
| 出版商 | Churchill Livingstone | |||||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-妇产科学 | |||||||||||||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||
| 出版周期 | Bi-monthly | |||||||||||||||||||||||||||||||
| 出版年份 | 1992 | |||||||||||||||||||||||||||||||
| 年文章数 | 135点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
| Gold OA文章占比 | 99.28% | |||||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 92.59% | |||||||||||||||||||||||||||||||
| WOS期刊JCR分区 （ 2024-2025年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||||||||
| 中国科学院《国际期刊预警 名单（试行）》名单 | 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||||
| 中国科学院期刊分区 （ 2025年3月最新升级版） | 点击查看中国科学院期刊分区趋势图
| |||||||||||||||||||||||||||||||
| 中国科学院期刊分区 （ 2023年12月升级版） |
| |||||||||||||||||||||||||||||||
| 中国科学院期刊分区 （ 2022年12月旧的升级版） |
| |||||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) 中科院的全球OA期刊索引（OAJ） | |||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0960-9776%5BISSN%5D | |||||||||||||||||||||||||||||||
| 平均审稿速度 | 期刊官网数据： 平均Submission to first decision: 7 days; Submission to decision after review: 49 days; Submission to acceptance: 93 days; Acceptance to online publication: 2 days; 网友分享经验： 平均1月 | |||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 12% | |||||||||||||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费：需要（ USD3520; ） 文章处理费豁免：查看说明 其他费用：没有 APC费用补充说明：Original Research Articles: USD 3520; Reviews: USD 3520; Short Communications: USD 1560; Debates: USD 1560; Viewpoints: USD 1560; Case Reports: USD 1560; LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！ | |||||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在BREAST顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||
| 编辑信息 | Editor-in-Chief Fatima Cardoso, MD, MSc ABC Global Alliance, Lisbon, Portugal Deputy Editor Karen Gelmon, MD FRCPC BC Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada | |||||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Tall Cell Carcinoma with Reversed Polarity of the breast: Clinicopathological insights, molecular profile, and future therapeutic directions Author: Lu, Ye; Kong, Xiangyi; Zhang, Wenxiang; Wang, Xiangyu; Pei, Shengbin; Fang, Yi; Gao, Jidong; Wang, Jing Journal: BREAST. 2025; Vol. 82, Issue , pp. -. DOI: 10.1016/j.breast.2025.104501 PubMed DOI |
| 2. | Explainable machine learning model for predicting internal mammary node metastasis in breast cancer: Multi-method development and cross-cohort validation Author: Xiang, Yirong; Tie, Jian; Zhang, Siyuan; Shi, Chen; Guo, Changkuo; Peng, Yushuo; Fan, Zhaoqing; Wang, Weihu Journal: BREAST. 2025; Vol. 82, Issue , pp. -. DOI: 10.1016/j.breast.2025.104517 PubMed DOI |
| 3. | Development and validation of a 10-gene signature for predicting recurrence risk in HR+/HER2-early breast cancer undergoing chemo-endocrine therapy Author: Wu, Xiaoyan; Lu, Xunxi; Zhang, Wenchuan; Zhong, Xiaorong; Bu, Hong; Zhang, Zhang Journal: BREAST. 2025; Vol. 82, Issue , pp. -. DOI: 10.1016/j.breast.2025.104484 PubMed DOI |
| 4. | Options for postoperative radiation therapy in patients with de novo metastatic breast cancer Author: Li, Chaofan; Wang, Yusheng; Fang, Biyun; Liu, Mengjie; Sun, Shiyu; Qu, Jingkun; Zhang, Shuqun; Du, Chong Journal: BREAST. 2025; Vol. 82, Issue , pp. -. DOI: 10.1016/j.breast.2025.104483 PubMed DOI |
| 5. | Trends in the global, national, and regional burden of breast cancer among adolescents and young adults from 1990 to 2021: Analyses of the 2021 global burden of disease study Author: Qian, Da; Hong, Weimin; Li, Shujin; Liu, Haotian; He, Chaoqi; Liu, Xiaozhen; Huang, Guoxin; Meng, Xuli; Zheng, Yiwen Journal: BREAST. 2025; Vol. 82, Issue , pp. -. DOI: 10.1016/j.breast.2025.104486 PubMed DOI |
| 6. | Effect of AI-based pre-hospital health education via QR code on APAIS scores in patients with breast nodules: A retrospective study Author: Ma, Guozhen; Miao, Chuyuan; Jiang, Pengjun; He, Guiqing; Li, Huiping; Huang, Yanhui; Yu, Huiwen; Chen, Tianwen Journal: BREAST. 2025; Vol. 82, Issue , pp. -. DOI: 10.1016/j.breast.2025.104481 PubMed DOI |
| 7. | Efficacy of adjuvant capecitabine in triple-negative breast cancer with residual disease after neoadjuvant therapy: a real-world study Author: Ma, Youzhao; Zhu, Mingda; Zhang, Jingyang; Jiao, Dechuang; Hou, Yangyang; Chen, Xiuchun; Liu, Zhenzhen Journal: BREAST. 2025; Vol. 81, Issue , pp. -. DOI: 10.1016/j.breast.2025.104477 PubMed DOI |
| 8. | Analysis of factors influencing chemotherapy-induced peripheral neuropathy in breast cancer patients using a random forest model Author: Xu, Huiqian; Li, Hong; Fan, Yijing; Wang, Yaqi; Li, Zeyuan; Zhou, Lizhi; Hao, Xijun Journal: BREAST. 2025; Vol. 81, Issue , pp. -. DOI: 10.1016/j.breast.2025.104457 PubMed DOI |
| 9. | Influence of surgical timing post-neoadjuvant chemotherapy on survival outcomes in breast cancer patients: A comprehensive systematic review and meta-analysis Author: Wang, Dandan; Sun, Xiaowei; Sun, Wen; Wang, Ruoxi; Pan, Hong; Zhou, Wenbin Journal: BREAST. 2025; Vol. 81, Issue , pp. -. DOI: 10.1016/j.breast.2025.104454 PubMed DOI |
| 10. | Prognostic factors and treatment insights for metastatic malignant phyllode tumors Author: Han, Mengjia; Zhang, Yunyi; Lei, Rong; Lai, Zijia; Zhuang, Zilin; Zhang, Yulu; Li, Xun; Li, Xiaojun; Jia, Rurong; Jiang, Qiongchao; Ye, Feng; Nie, Yan Journal: BREAST. 2025; Vol. 81, Issue , pp. -. DOI: 10.1016/j.breast.2025.104455 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| Springer发布AI审稿筛查工具：科研人怎么看？加入讨论 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共43条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
